Research Roundup

Debbie Rigby rounds up the latest in research news High use of short-acting beta-2-agonists in COPD is associated with an increased risk of exacerbations and mortality This observational study from Sweden showed high use of SABAs in patients with COPD. 15.5% of patients had collected ≥3 SABA canisters, and 7.0% ≥6 SABA canisters during a